Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

The Etiology of Prostate Cancer

Keng Lim Ng  1
Simon RJ Bott  1 , Keng Lim Ng  1
, editors.
In: Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. Chapter 2.
Affiliations
Free Books & Documents
Review

The Etiology of Prostate Cancer

Keng Lim Ng.
Free Books & Documents

Excerpt

While the exact etiology of prostate cancer remains elusive, various modifiable and unmodifiable risk factors have been suggested as contributing factors. These include age, ethnicity, family history, genetics, obesity, diet, hormones, smoking, alcohol, and certain medications; however, none of these, perhaps with the exception of ethnicity and age, has been conclusively proven to be a definite etiological factor for prostate cancer. Men of black African ancestry are more prone to the disease. The probability of developing prostate cancer increases with age, from 0.005% in men younger than 39 years of age to 2.2% in men between 40 and 59 years, and 13.7% in men between 60 and 79 years. A better understanding of the environmental, genetic, nutritional, hormonal, and molecular landscape that shape the etiology and pathophysiology of prostate cancer will lead to better preventative strategies, enhanced diagnostic pathways, and improved management of the disease. This chapter provides an overview of the current understanding of the etiology of prostate cancer.

PubMed Disclaimer

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492. - DOI - PubMed
    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210. - DOI - PubMed
    1. Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK. Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J Urol. 1997;158(4):1427–30. https://doi.org/10.1016/S0022-5347(01)64231-9. - DOI - PubMed
    1. Carter HB, Piantadosi S, Isaacs JT. Clinical evidence for and implications of the multistep development of prostate cancer. J Urol. 1990;143(4):742–6. https://doi.org/10.1016/S0022-5347(17)40078-4. - DOI - PubMed
    1. Kalish LA, McDougal WS, McKinlay JB. Family history and the risk of prostate cancer. Urology. 2000;56(5):803–6. https://doi.org/10.1016/S0090-4295(00)00780-9. - DOI - PubMed

LinkOut - more resources